Patient derived lung cancer explants as a platform for validation of the correlation between CD320 and mutant p53

Project: FDCRGP

Project Details

Grant Program

Faculty Development Competitive Research Grant Program (General) 2024-2026

Project Description

The goal of the project is to investigate the role of p53 in the protein translation, effects of p53 protein on its novel translational targets, such as CD320, and validate CD320 as a potential clinical marker for p53 mutants and potential therapeutic target for tumour-specific drug delivery in lung cancer.
StatusActive
Effective start/end date1/1/2412/31/26

Keywords

  • Explants
  • Lung cancer
  • CD320
  • Mutp53
  • Targeted drug delivery

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.